On the occasion of Multiple Sclerosis Awareness Week 2022, the national extension of the virtual exhibition “Living with MS during COVID-19: A case for rethinking MS care in the EU” brings light to the impact of the COVID-19 pandemic on multiple sclerosis at country level.

Impact of the COVID-19 pandemic on multiple sclerosis at national level

The COVID-19 pandemic affected us all, but it did not affect us all equally. People living with chronic conditions, such as multiple sclerosis (MS), have faced uncertainty and disruption in their care pathways, and, as a consequence, have dealt and will continue to deal with long-term physical and emotional implications of not receiving optimal care.

National stakeholders across Europe want to make a difference in how MS care and treatment are delivered. They call for the need to rethink MS and MS care in terms of coordination, integration and prioritisation in order to ensure optimal care for people living with MS in Europe. In the extended exhibition, experts from Belgium, the Czech Republic, France, Germany and the United Kingdom share unique insights on MS care during the COVID-19 pandemic. 

RETHINKING MS in Europe

The virtual exhibition “Living with MS during COVID-19: A case for rethinking MS care in the EU”, initially launched on the World MS Day 2021, is part of the research project RETHINKING MS in Europe, coordinated by EBC. The aim of the project is to create greater visibility for the unmet needs experienced by people with MS, with a particular focus on three key areas: timely diagnosis and personalised treatment; interdisciplinary and coordinated care; and adaptable support in daily life, including rehabilitation and social protection.

Visit the extended exhibition now and hear from the experts on how the MS care was tackled during the COVID-19 pandemic in Belgium, the Czech Republic, France, Germany and the United Kingdom.